Form 8-K · Current report
News Corp 8-K, filed Aug 20, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000184
Summary
News Corp reported to the Australian Securities Exchange that it bought back 58,482 shares on August 19, 2026 for about US$1.73 million, under a repurchase program authorizing up to US$1 billion of its Nasdaq-listed Class A and Class B common stock. The company has repurchased roughly US$433.7 million worth of Class A and Class B shares to date under the program, which was authorized as of July 15, 2025.
Key points
- Cumulative buybacks under the 2025 Repurchase Program totaled 10,962,955 shares for US$281,347,236.24 as of August 19, 2026.
- Goldman Sachs & Co. LLC is named as the broker for the repurchases.
- No ASX-listed CDIs will be repurchased under the program, and no shareholder approval is required.
- News Corp stated the reason for the buyback is to enhance shareholder value.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.